📑Suministro de los medicamentos VEMURAFENIB (DOE), COBIMETINIB (DOE), DORNASA ALFA (DOE) Y PEG INTERFERON ALFA 2A (DOE) para todas las organizaciones de servicios de Osakidetza y centros vinculados
Procurement process summary
This process is to purchase Suministro de los medicamentos VEMURAFENIB (DOE), COBIMETINIB (DOE), DORNASA ALFA (DOE) Y PEG INTERFERON ALFA 2A (DOE) para todas las organizaciones de servicios de Osakidetza y centros vinculados.
This contract was awarded by 🇪🇸 Osakidetza for an amount of EUR 174,622 to 1 supplier. It was published on 2024-01-12 through direct
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇸 Osakidetza Buying unitnot reported Publication date2024-01-12 Contest statusnot reported DescriptionEl presente expediente tiene por objeto la contratacion centralizada del suministro de los medicamentos VEMURAFENIB (DOE), COBIMETINIB (DOE), DORNASA ALFA (DOE) Y PEG INTERFERON ALFA 2A (DOE) para todas las organizaciones de servicios de Osakidetza y centros sanitarios de titularidad privada y sin animo de lucro, ubicados en la Comunidad Autonoma de Euskadi, dentro del marco previsto en el articulo 30 de la Ley 8/1997, de 26 de junio, de Ordenacion Sanitaria de Euskadi, que suscriban un convenio de vinculacion con Osakidetza/Servicio vasco de salud. Con este expediente de contratacion cuyas condiciones quedan establecidas en el presente pliego, se pretende cubrir el uso del medicamento incluido en el expediente para satisfacer las El presente necesidades clinicas de los pacientes de Osakidetza y centros vinculados que estan resumidas en la memoria del expediente.Awards
This award was granted to ROCHE FARMA, S.A by Osakidetza for an amount of EUR 174,622. The procurement process was conducted through direct for the category of goods. The award was granted on 2022-03-10. This is award number 3.
This contract has multiple awards. This is award number 3. View other awards for this contract
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇪🇸 ROCHE FARMA, S.A | EUR 174,622 | 2022-03-10 | 3 |
Market context and opportunities
The execution of this contract allows the entity Osakidetza to fulfill its public service objectives efficiently.
The direct purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberES_ocds-70d2nz-1a01f6ec-8836-479a-b51a-c003dd7f549e-award-3Publication date2024-01-12Contract datenot reportedAward date2022-03-10CategoriesgoodsPurchase modalitydirectMethod detailspt_award_contract_without_callStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
